Explore By Subject Area   

Accelerating Evaluations of New Device Technologies for Complex Formulations

Representatives from Genentech, Windgap Medical, Cambridge Design Partnerships, Datwyler and GSK discuss approaches to streamline development of combination products for complex formulations.

July 25, 2025
Accelerating Evaluations of New Device Technologies for Complex Formulations

Summary:

Representatives from Genentech, Windgap Medical, Cambridge Design Partnerships, Datwyler and GSK discuss approaches to streamline development of combination products for complex formulations, including:

  • How they evaluate the needs of complex formulations
  • Developing criteria to evaluate new device technologies
  • Strategies to de-risk and accelerate product development
  • Balancing and prioritizing cost vs risk


This conversation took place at the 2024 PODD: Partnership Opportunities in Drug Delivery Conference. To learn more, please visit Drug-Delivery.org.

Moderator Panelists

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.